Rothhammer et al. (2016) showed that gut-derived tryptophan metabolites can increase aryl hydrocarbon receptor (Ahr) signaling, which can suppress astrocytic inflammation in the EAE model of MS [40]. Here, AHR is linked to myeloid sarcoma.